Benzinga | Mar 10, 2021 07:08AM EST

Harvard Bioscience Q4 Adj. EPS $0.08 Beats $0.06 Estimate, Sales $31.00M Beat $27.13M Estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.06 by 33.33 percent. This is unchanged from the same period last year. The company reported quarterly sales of $31.00 million which beat the analyst consensus estimate of $27.13 million by 14.26 percent. This is a 0.09 percent increase over sales of $30.97 million the same period last year.